Superior Biomarker quantification, with robust performance and high sensitivity.

Chimera Biotec is a highly experienced provider of ultra sensitive biomarker sample testing supporting all phases of drug development from discovery to preclinical and clinical studies. We have a broad track record in supporting trials in a wide range of disease areas including inflammatory, oncology, neurology (CNS), infectious and metabolic diseases. Virtually any matrix can be supported using the outstanding tolerance of the Imperacer® platform for high sample dilution, and still maintaining extreme sensitivities.

PD literature list

Clinical Biomarker Quantification: Novel Tools for Pharmacodynamic Applicationsrequest reprint
Challenges in Developing a Sensitive PD Assay–From Tool Selection to Technologies Evaluationrequest reprint